US stock market: S&P 500, Nasdaq end lower on first day of August in busy earnings week
Among pharmaceutical heavyweights, Pfizer edged lower in choppy trading after the drugmaker’s quarterly revenue fell short of Wall Street expectations, hit by declining sales of its COVID-19 products.
